HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of radiation synovectomy with Yttrium-90 and Samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled, randomized, double-blinded trial.

Abstract
The aim of the present study was to investigate the long-term effectiveness of and tolerance to Yttrium-90 and Samarium-153-particulate hydroxyapatite radiation synovectomy in patients with rheumatoid arthritis (RA) and chronic knee synovitis. Eight-four patients (90 knees) with chronic knee synovitis and RA (according to the American College of Rheumatology criteria) participated in a controlled, double-blinded trial. Patients were randomized to receive an intra-articular injection with either 5 mCi Yttrium-90 plus 40 mg of triamcinolone hexacetonide (Y/TH Group), 15 mCi Samarium-153 hydroxyapatite plus 40 mg of triamcinolone hexacetonide (Sm/TH Group), or 40 mg triamcinolone hexacetonide alone (Control Group). Blinded examination at baseline, 1, 4, 12, 32, and 48 weeks post-intervention included a visual analog scale for joint pain and swelling, morning stiffness, range of motion, knee circumference, Likert scale, percentage of improvement, Stanford Health Assessment Questionnaire, Lequesne index, use of non-steroidal anti-inflammatory drugs and corticosteroids, events and adverse effects, calls to the physician, and hospital visits. There were three withdrawals prior to the injections. Regarding the pain, there was a significantly better response in the Y/TH Group versus the Sm/TH Group at T1 (p = 0.025) and versus TH alone at T48 (p = 0.026). The Sm/TH group had more adverse effects (p = 0.042), but these were mild and transitory. For the pain parameter alone, Yttrium-90 radiosynovectomy associated to TH proved superior to Samarium-153 hydroxyapatite radiosynovectomy associated to TH at T1 and to synovectomy with TH at T48. No other statistically significant inter-group differences were detected.
AuthorsMarla Francisca Dos Santos, Rita Nely Vilar Furtado, Monique Sayuri Konai, Mario Luiz Vieira Castiglioni, Renata Rosa Marchetti, Constancia Pagano Gonçalves Silva, Jamil Natour
JournalClinical rheumatology (Clin Rheumatol) Vol. 30 Issue 1 Pg. 77-85 (Jan 2011) ISSN: 1434-9949 [Electronic] Germany
PMID21120562 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Radioisotopes
  • Yttrium Radioisotopes
  • Samarium
  • Durapatite
  • Triamcinolone Acetonide
  • triamcinolone hexacetonide
Topics
  • Arthritis, Rheumatoid (metabolism)
  • Chronic Disease
  • Double-Blind Method
  • Durapatite (chemistry)
  • Female
  • Humans
  • Knee Joint (metabolism)
  • Male
  • Middle Aged
  • Radioisotopes (pharmacology)
  • Samarium (pharmacology)
  • Surveys and Questionnaires
  • Synovitis (metabolism, pathology)
  • Triamcinolone Acetonide (analogs & derivatives, pharmacology)
  • Yttrium Radioisotopes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: